Table 2 Characteristics of patients with and without hepatic steatosis after liver transplantation
Steatosis (+) (n = 54) | Steatosis (-) (n = 49) | P-value | |
|---|---|---|---|
Age (year) | 50.92 ± 9.24 | 51.02 ± 12.02 | 0.964 |
Sex (men/women) | 35/19 | 30/19 | 0.706 |
Weight (kg) | 79.83 ± 16.00 | 71.89 ± 15.02 | 0.011 |
Height (cm) | 169.73 ± 9.71 | 166.35 ± 10.55 | 0.099 |
BMI (kg/m2) | 27.65 ± 5.12 | 26.11 ± 6.48 | 0.185 |
PTDM, n (%) | 33 (64.7) | 23 (48.9) | 0.115 |
Hyperlipidemia, n (%) | 35 (64.8) | 24 (49) | 0.105 |
Hypertension, n (%) | 40 (74.1) | 42 (85.7) | 0.143 |
Etiology, n (%) | 0.008 | ||
NASH | 34 (63) | 18 (36.7) | |
Non -NASH | 20 (37) | 31 (63.3) | |
AST (IU/L) | 26.70 ± 11.88 | 24.40 ± 12.35 | 0.352 |
ALT (IU/L) | 34.29 ± 20.53 | 28.13 ± 20.09 | 0.142 |
ALK. Ph (IU/L) | 236.33 ± 101.55 | 258.04 ± 126.44 | 0.354 |
T. Bilirubin (mg/dL) | 1 ± 4.58 | 0.93 ± 0.51 | 0.516 |
D.Bilirubin (mg/dL) | 0.35 ± 0.25 | 0.33 ± 0.28 | 0.626 |
FBS (mg/dL) | 148.70 ± 76.35 | 122.87 ± 54.74 | 0.059 |
TG (mg/dL) | 234.94 ± 147.76 | 165.10 ± 81.85 | 0.006 |
Cholesterol (mg/dL) | 184.94 ± 68.12 | 190.73 ± 48.48 | 0.634 |
HDL (mg/dL) | 40.94 ± 12.81 | 46.15 ± 14.28 | 0.061 |
LDL (mg/dL) | 94.43 ± 40.54 | 106.89 ± 33.76 | 0.105 |
Rejection, n (%) | 19 (36.5) | 13 (26.5) | 0.280 |
ARB, n (%) | 11 (20.4%) | 24 (49%) | 0.002 |